» Articles » PMID: 39624109

Combination Therapy of Phytonanomedicine and Post-biotic for the Management of Parkinson's Disease

Overview
Journal EXCLI J
Specialty Biology
Date 2024 Dec 3
PMID 39624109
Authors
Affiliations
Soon will be listed here.
References
1.
Liu X, Bai J, Jiang C, Song Z, Zhao Y, Nauwynck H . Therapeutic effect of Xanthohumol against highly pathogenic porcine reproductive and respiratory syndrome viruses. Vet Microbiol. 2019; 238:108431. DOI: 10.1016/j.vetmic.2019.108431. View

2.
Lee I, Lim J, Gal J, Kang J, Kim H, Kang B . Anti-inflammatory activity of xanthohumol involves heme oxygenase-1 induction via NRF2-ARE signaling in microglial BV2 cells. Neurochem Int. 2010; 58(2):153-60. DOI: 10.1016/j.neuint.2010.11.008. View

3.
Jiang C, Sun T, Xiang D, Wei S, Li W . Anticancer Activity and Mechanism of Xanthohumol: A Prenylated Flavonoid From Hops ( L.). Front Pharmacol. 2018; 9:530. PMC: 5972274. DOI: 10.3389/fphar.2018.00530. View

4.
Alves G, Muller B, Herlofson K, HogenEsch I, Telstad W, Aarsland D . Incidence of Parkinson's disease in Norway: the Norwegian ParkWest study. J Neurol Neurosurg Psychiatry. 2009; 80(8):851-7. DOI: 10.1136/jnnp.2008.168211. View

5.
Zhang Y, Xu S, Qian Y, Mo C, Ai P, Yang X . Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson's disease by regulating gut microbiota. Front Aging Neurosci. 2023; 15:1099018. PMC: 9905700. DOI: 10.3389/fnagi.2023.1099018. View